Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
34.16 USD | +1.85% | +4.12% | +53.35% |
02/05 | Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss | MT |
02/05 | Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.35% | 190.42Cr | |
+5.34% | 11TCr | |
+12.40% | 11TCr | |
-12.91% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-11.31% | 1.7TCr | |
+5.00% | 1.37TCr | |
+36.56% | 1.24TCr |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- RBC Raises Price Target on Agios Pharmaceuticals to $67 From $61, Maintains Outperform Rating